 -- Industry veteran with over than two decades of experience in medical affairs to lead clinical and medical affairs at Femasys -- ATLANTA, Sept. 01, 2021 GLOBE NEWSWIRE -- Femasys Inc. NASDAQ: FEMY, a biomedical company developing a suite of product candidates to transform womens healthcare with minimally invasive, non-surgical, in-office technologies, today announced the appointment of Edward G. Evantash, M.D., as chief medical officer. Dr. Evantash brings over two decades of industry experience in medical and clinical affairs to Femasys, having previously served as chief medical officer of Alydia Health and vice president of medical affairs at Hologic, Inc., both medical technology companies focused on womens healthcare. He will be responsible for providing leadership and direction for Femasys pipeline of clinical development programs. 